Imunon EPS
The Earnings per Share (EPS) of Imunon (IMNN) as of Oct 19, 2026 is -6.83 USD. In the previous year, Earnings per Share (EPS) was -16.75 USD — a change of -59.24% (higher).
Get this data via API
Financial Data API
EPS
-6.83USD
YoY
-59.24%
Last updated:
The Imunon EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| est | -1.04USD | -14.11% |
| est | -1.21USD | -11.72% |
| est | -1.37USD | -22.99% |
| est | -1.77USD | -24.09% |
| est | -2.34USD | -65.80% |
| -6.83USD | -59.24% | |
| -16.75USD | -38.14% | |
| -27.08USD | -57.00% | |
| -62.97USD | +34.13% | |
| -46.95USD | -54.55% | |
| -103.29USD | -27.12% | |
| -141.73USD | +14.85% | |
| -123.40USD | -75.75% | |
| -508.78USD | +212.14% | |
| -163.00USD | -94.92% | |
| -3,208.73USD | -25.74% | |
| -4,321.06USD | +125.18% | |
| -1,918.92USD | -81.94% | |
| -10,627.20USD | -26.78% | |
| -14,514.17USD | -30.59% | |
| -20,909.37USD | +10.10% | |
| -18,991.25USD | +12.79% | |
| -16,837.45USD | -138.11% | |
| 44,186.32USD | -566.09% | |
| -9,480.29USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Imunon Stock analysis
Frequently Asked Questions about Imunon stock
Earnings per Share (EPS) of Imunon is -6.83 USD in 2025.
Earnings per Share (EPS) of Imunon changed from -16.75 USD to -6.83 USD, representing a -59.24% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Imunon since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Imunon
All Key Metrics — Imunon
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth